Altumomab
WikiDoc Resources for Altumomab |
Articles |
---|
Most recent articles on Altumomab |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Altumomab at Clinical Trials.gov Clinical Trials on Altumomab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Altumomab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Altumomab Discussion groups on Altumomab Directions to Hospitals Treating Altumomab Risk calculators and risk factors for Altumomab
|
Healthcare Provider Resources |
Causes & Risk Factors for Altumomab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Altumomab is a mouse monoclonal antibody and which it's used to treat cancers. It has a radioisotope, indium (In 111) which it's added.